CORC

在结果中检索

CORC

浏览/检索结果: 共14条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells 期刊论文
THORACIC CANCER, 2021, 页码: 9
作者:  Zhang, Mi;  Quan, Haitian;  Fu, Li;  Li, Yun;  Fu, Haoyu
收藏  |  浏览/下载：19/0  |  提交时间：2021/05/24
Discovery of a potent tyrosine kinase AXL inhibitor bearing the 3-((2,3,4,5-tetrahydro-1H-benzo [d] azepin-7-yl)amino)pyrazine core 期刊论文
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 卷号: 29, 期号: 6, 页码: 836-838
作者:  Wang, Yueliang;  Xing, Li;  Ji, Yinchun;  Ye, Jiqing;  Dai, Yang
收藏  |  浏览/下载：16/0  |  提交时间：2020/07/01
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models 期刊论文
ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 2, 页码: 243-250
作者:  Jiang, Xi-fei;  Dai, Yang;  Peng, Xia;  Shen, Yan-yan;  Su, Yi
收藏  |  浏览/下载：54/0  |  提交时间：2019/01/08
SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models 期刊论文
ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 2
作者:  Jiang, Xi-fei;  Dai, Yang;  Peng, Xia;  Shen, Yan-yan;  Su, Yi
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Identifying egfr-expressed cells and detecting egfr multi-mutations at single-cell level by microfluidic chip 期刊论文
Nano-micro letters, 2018, 卷号: 10, 期号: 1, 页码: 10
作者:  Li, Ren;  Zhou, Mingxing;  Li, Jine;  Wang, Zihua;  Zhang, Weikai
收藏  |  浏览/下载：92/0  |  提交时间：2019/04/23
Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer 期刊论文
ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38, 期号: 11, 页码: 1533-1542
作者:  Xie, Qin;  Chen, Hui;  Ai, Jing;  Gao, Ying-lei;  Geng, Mei-yu
收藏  |  浏览/下载：17/0  |  提交时间：2019/01/08
Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 126, 页码: 122-132
作者:  Liu, Yang;  Peng, Xia;  Guan, Xiaocong;  Lu, Dong;  Xi, Yong
收藏  |  浏览/下载：42/0  |  提交时间：2019/01/08
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1
作者:  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua;  Wang, Zhehai
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/04
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 页码: S886-S887
作者:  Han, Baohui;  Li, Kai;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载：9/0  |  提交时间：2019/11/26
A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2017, 卷号: 12, 期号: 1, 页码: S886-S887
作者:  Han, Baohui;  Li, Kai;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/12

©版权所有 ©2017 CSpace - Powered by CSpace